SCM
CLPT icon

Sterling Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Sterling Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61K Hold
177
– – ﹤0.01% 3029
2025
Q4 		$2.42K Buy
177
+113
+177% +$2.1K ﹤0.01% 3043
2025
Q3 		$1.4K Buy
64
+1
+2% +$12 ﹤0.01% 3032
2025
Q2 		$752 Buy
+63
New +$793 ﹤0.01% 3105

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sterling Capital Management's CLPT Position: Q1 2026 in Review

Sterling Capital Management held its ClearPoint Neuro (CLPT) position steady in Q1 2026 at 177 shares worth $1.61K. The position accounts for ﹤0.01% of the portfolio, ranked #3029.

Sterling Capital Management first reported a position in CLPT in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.42K in Q4 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Sterling Capital Management held 177 shares of ClearPoint Neuro worth $1.61K as of Q1 2026.
  • Sterling Capital Management left its ClearPoint Neuro share count unchanged in Q1 2026.
  • ClearPoint Neuro made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #3029 holding.
  • Sterling Capital Management first reported a position in ClearPoint Neuro in Q2 2025 and has held it in 4 quarters since.
  • Sterling Capital Management's ClearPoint Neuro position peaked at $2.42K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.